Although no somatic AIP mutation has been described in pituitary adenomas to date [4, 6], approximately half of the sporadic somatotropinomas present with low intrinsic AIP expression, and, similar to the mutated tumors, most of them are invasive and respond poorly to SSA therapy [7–9]. The gene discussed is AIP; the disease is growth hormone-producing pituitary gland neoplasm.